This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

The Changing Landscape and Treatment Paradigm in ATTR-CM

Prescribing information can be found at the bottom of the page.


Join us on 12 June 2024 to hear from Dr Andrew Frett, Consultant Cardiologist & Dr Catherine Mercer, Consultant Clinical Geneticist discussing 'The Changing Landscape and Treatment Paradigm in ATTR-CM' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for GB HCPs and may include reference to medicines or vaccines promoted by Pfizer.   

Prescribing information can be found at the bottom of the page.


Join us on 12 June 2024 to hear from Dr Andrew Frett, Consultant Cardiologist & Dr Catherine Mercer, Consultant Clinical Geneticist discussing 'The Changing Landscape and Treatment Paradigm in ATTR-CM' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for GB HCPs and may include reference to medicines or vaccines promoted by Pfizer.   

Event Date12 June 2024 18:30 BSTDuration1 Hr 40 AudienceConsultants, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 18:15 - 18:30Joining & Registration
18:30 - 18:35Welcome & Introduction Sharon Amesbury, Pfizer Ltd
18:35 - 19:10The Changing Landscape and Treatment Paradigm in ATTR-CM Andrew Flett - Dr
19:10 - 19:30Vyndaqel® (tafamidis) Case Studies Andrew Flett - Dr
19:30 - 19:50Genetics for ATTR-CM Catherine Mercer - Dr
19:50 - 20:05Questions & Answer Catherine Mercer - Dr Andrew Flett - Dr
20:05 - 20:10Final Remarks Sharon Amesbury, Pfizer Ltd
20:10Meeting Close
Speakers
Event Speakers
Andrew Flett, Dr
Andrew Flett, DrConsultant Cardiologist, University Hospital Southampton NHS Foundation Trust

Dr Andrew Flett is a consultant cardiologist at University Hospital Southampton NHS Trust since 2013. He has a special interest in heart failure and cardiomyopathy having trained at the Heart Hospital (UCLH London). He is the chief investigator of the BRITISH study – a multicenter trial of defibrillators in non ischemic cardiomyopathy. He has published widely in the field of cardiac MRI and cardiomyopathy. 

 

 

Catherine Mercer, Dr
Catherine Mercer, DrConsultant Clinical Geneticist, University Hospital Southampton NHS Foundation Trust

Catherine is a Consultant Clinical Geneticist at University Hospital Southampton NHS Foundation Trust and is the lead clinician for Cardiac Genetics across the Wessex region. Catherine has developed the Cardiac Genetics Service across the region to increase clinical capacity and ensure equity of patient access across the region.   In addition, Catherine was the Rare Disease Lead for the 100,000 Genomes Project in Wessex, involved in driving the delivery of this NHS transformational project.  

Catherine also has a research background with a PhD in the molecular genetic causes of congenital heart disease, specifically left ventricular outflow tract obstruction.  Catherine is the past secretary for the AICC, the UK National Professional body for experts caring for those with Inherited Cardiac Conditions.

Vyndaqel®(tafamidis) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-VYN-GBR-1444. May 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​